1
|
Tao M, Ma D, Li Y, et al: Clinical
significance of circulating tumor cells in breast cancer patients.
Breast Cancer Res Treat. 129:247–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bazou D, Santos-Martinez MJ, Medina C and
Radomski MW: Elucidation of flow-mediated tumour cell-induced
platelet aggregation using an ultrasound standing wave trap. Br J
Pharmacol. 162:1577–1589. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Peng F, Wei YQ, Tian L, et al: Induction
of apoptosis by norcantharidin in human colorectal carcinoma cell
lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin
Oncol. 128:223–230. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chen YN, Chen JC, Yin SC, et al: Effector
mechanisms of norcantharidin-induced mitotic arrest and apoptosis
in human hepatoma cells. Int J Cancer. 100:158–165. 2002.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Huan SK, Lee HH, Liu DZ, Wu CC and Wang
CC: Cantharidin-induced cytotoxicity and cyclooxygenase 2
expression in human bladder carcinoma cell line. Toxicology.
223:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Williams LA, Moller W, Merisor E, Kraus W
and Rosner H: In vitro anti-proliferation/cytotoxic activity of
cantharidin (Spanish Fly) and related derivatives. West Indian Med
J. 52:10–13. 2003.PubMed/NCBI
|
7
|
Li W, Xie L, Chen Z, et al: Cantharidin, a
potent and selective PP2A inhibitor, induces an oxidative
stress-independent growth inhibition of pancreatic cancer cells
through G2/M cell-cycle arrest and apoptosis. Cancer Sci.
101:1226–1233. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li W, Chen Z, Zong Y, et al: PP2A
inhibitors induce apoptosis in pancreatic cancer cell line PANC-1
through persistent phosphorylation of IKKα and sustained activation
of the NF-κB pathway. Cancer Lett. 304:117–127. 2011.PubMed/NCBI
|
9
|
Li W, Chen Z, Gong FR, et al: Growth of
the pancreatic cancer cell line PANC-1 is inhibited by protein
phosphatase 2A inhibitors through overactivation of the c-Jun
N-terminal kinase pathway. Eur J Cancer. 47:2654–2664. 2011.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Carmichael J, DeGraff WG, Gazdar AF, Minna
JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated
colorimetric assay: assessment of chemosensitivity testing. Cancer
Res. 47:936–942. 1987.PubMed/NCBI
|
11
|
Zhang G, Han J, Welch EJ, et al:
Lipopolysaccharide stimulates platelet secretion and potentiates
platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein
kinase pathway. J Immunol. 182:7997–8004. 2009. View Article : Google Scholar
|
12
|
Egan K, Crowley D, Smyth P, et al:
Platelet adhesion and degranulation induce pro-survival and
pro-angiogenic signalling in ovarian cancer cells. PLoS One.
6:e261252011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Erpenbeck L and Schon MP: Deadly allies:
the fatal interplay between platelets and metastasizing cancer
cells. Blood. 115:3427–3436. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Lett. 330:283–286. 1993.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Millward TA, Zolnierowicz S and Hemmings
BA: Regulation of protein kinase cascades by protein phosphatase
2A. Trends Biochem Sci. 24:186–191. 1999. View Article : Google Scholar : PubMed/NCBI
|
16
|
Schonthal AH: Role of serine/threonine
protein phosphatase 2A in cancer. Cancer Lett. 170:1–13. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Kim YJ, Borsig L, Varki NM and Varki A:
P-selectin deficiency attenuates tumor growth and metastasis. Proc
Natl Acad Sci USA. 95:9325–9330. 1998. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhang N, Zhang WJ, Cai HQ, et al: Platelet
adhesion and fusion to endothelial cell facilitate the metastasis
of tumor cell in hypoxia-reoxygenation condition. Clin Exp
Metastasis. 28:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Biggerstaff JP, Seth N, Amirkhosravi A, et
al: Soluble fibrin augments platelet/tumor cell adherence in vitro
and in vivo, and enhances experimental metastasis. Clin Exp
Metastasis. 17:723–730. 1999. View Article : Google Scholar : PubMed/NCBI
|
20
|
Karpatkin S, Pearlstein E, Ambrogio C and
Coller BS: Role of adhesive proteins in platelet tumor interaction
in vitro and metastasis formation in vivo. J Clin Invest.
81:1012–1019. 1988. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chiang HS, Yang RS and Huang TF: The
Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell
adhesion to extracellular matrices and platelet aggregation caused
by saos-2 human osteosarcoma cells. Br J Cancer. 71:265–270. 1995.
View Article : Google Scholar
|
22
|
Xu J, Zutter MM, Santoro SA and Clark RA:
A three-dimensional collagen lattice activates NF-κB in human
fibroblasts: role in integrin α2gene expression and
tissue remodeling. J Cell Biol. 140:709–719. 1998.PubMed/NCBI
|
23
|
Eriksson M, Arminen L,
Karjalainen-Lindsberg ML and Leppa S: AP-1 regulates α2β1 integrin
expression by ERK-dependent signals during megakaryocytic
differentiation of K562 cells. Exp Cell Res. 304:175–186. 2005.
|
24
|
Janssens V, Goris J and Van Hoof C: PP2A:
the expected tumor suppressor. Curr Opin Genet Dev. 15:34–41. 2005.
View Article : Google Scholar : PubMed/NCBI
|